Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-12-08 Cohen Chad M Chief Financial Officer Sale −300 $52.38 $16K 1,000
2020-12-08 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −30,000 490,000
2020-12-07 BALDO LANCE Chief Medical Officer Option exercise +6,250 $7.80 $49K 6,250
2020-12-07 BALDO LANCE Chief Medical Officer Sale −780 $48.79 $38K 5,470
2020-12-07 BALDO LANCE Chief Medical Officer Sale −3,000 $50.14 $150K 2,470
2020-12-07 BALDO LANCE Chief Medical Officer Sale −2,470 $51.26 $127K 0
2020-12-07 BALDO LANCE Chief Medical Officer Option exercise · Stock Option (Right to Buy) −6,250 381,250
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 2,604
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 5,208
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise +1,562 $7.27 $11K 6,770
2020-12-01 BENZENO SHARON Chief Business Development Off Sale −3,077 $48.20 $148K 3,693
2020-12-01 BENZENO SHARON Chief Business Development Off Sale −3,693 $49.43 $183K 0
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 28,646
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −2,604 57,292
2020-12-01 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −1,562 39,063
2020-11-23 Taylor Stacy L SVP and General Counsel Option exercise +1,109 $7.80 $9K 2,409
2020-11-23 Taylor Stacy L SVP and General Counsel Option exercise +1,771 $6.55 $12K 4,180
2020-11-23 Taylor Stacy L SVP and General Counsel Sale −23 $45.69 $1K 4,157
2020-11-23 Taylor Stacy L SVP and General Counsel Sale −2,857 $46.31 $132K 1,300
2020-11-23 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,109 33,926

Page 81 of 120 · 2,386 trades